Company name:

Portola Pharmaceuticals Inc

  • IPO SHARE PRICE:
    $14.00
  • IPO DATE:
    22 May 2013
  • TICKER:
    PTLA
  • MAIN STOCK EXCHANGE:
    NASDAQ
  • CURRENT HQ LOCATION:
    270 E Grand Avenue South San Francisco California 94080
  • FISCAL YEAR END:
    December 31
  • INCORPORATION JURISDICTION:
    DE
  • ORGANIZED AS THE FOLLOWING LEGAL TYPE:
    Corporation
  • Investor Relations Webpage:
    Coming soon!
  • TAX RATE:
    USA federal corporate nominal income tax rate is 21%

Short Description

Portola Pharmaceuticals Inc

We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com

Balance Sheet

Quarterly Annual
(USD in thousand)
38.2% 32.5%
Selected Year:
31-Mar
2020
Current Assets
Most valuable part of Current Assets is Cash and Marketable Securities which should be watched carefully; at the same time high and growing level of Accounts Receivables is very dangerous sign
76.4%
38.2% —

Cash and cash equivalents

32.5% —

Short-term passive investments

2.0% —

Prepaid expenses and other current assets

1.4% —

Trade and other receivables

0.8% —

Restricted cash and cash equivalents

0.7% —

Inventory

0.7% —

Unbilled - collaboration and license revenue

Liquidity
Selected Year:
The most liquid asset, however, most companies don't keep much of it and invest excess cash into marketable securities such as Government bonds - in the US - Treasuries
Cash and cash equivalents
$45,679
$45,679
$45,679
$45,679
$45,679
 $181,568 $138,951 $215,229 $196,235
Short-term passive investments
$45,679
$45,679
$45,679
$45,679
$45,679
 281,589 178,013 214,054 166,661
Restricted cash and cash equivalents
-
-
$45,679
$45,679
$45,679
 173 1,062 3,421 4,274
Receivables from collaborators
$45,679
$45,679
$45,679
$45,679
$45,679
 - - - -
Trade and other receivables
-
-
-
-
-
 3,750 5,849 13,547 7,410
Unbilled - collaboration and license revenue
-
-
-
-
-
 - 9,880 3,783 3,408
Inventory
-
-
-
-
$45,679
 1,099 7,873 4,101 3,576
Prepaid research and development
-
-
$45,679
$45,679
$45,679
 - - - -
Prepaid expenses and other current assets
$45,679
$45,679
$45,679
$45,679
$45,679
 9,744 11,699 7,998 10,374
Total current assets
$45,679
$45,679
$45,679
$45,679
$45,679
 $477,923 $353,327 $462,133 $391,938
6.1% 13.7%
Selected Year:
31-Mar
2020
Non-Current Assets
Non-current assets characterize company's business: high Property, Plant, and Equipment means that company is in capital-intensive industry which typically is very cyclical (earnings fluctuate a lot); watch out for high level of Goodwill and other non-intangibles which is bad sign as they typically worth very low relative to their value shown on the balance sheet
23.6%
13.7% —

Inventories noncurrent portion

6.1% —

Long-term passive investments

2.2% —

Operating lease - right-of-use assets

0.9% —

Property and equipment net

0.7% —

Prepaid and other long-term assets
Selected Year:
Long-term passive investments
45,679
45,679
45,679
45,679
45,679
 71,076 - 36,961 31,164
Property and equipment net
45,679
45,679
45,679
45,679
45,679
 5,217 5,236 4,264 4,872
Operating lease - right-of-use assets
-
-
-
-
-
 - - 12,064 11,112
Inventories noncurrent portion
-
-
-
-
-
 - 9,645 56,096 70,439
Prepaid and other long-term assets
-
45,679
45,679
45,679
45,679
 9,609 10,932 6,965 3,781
Intangible assets
-
-
45,679
45,679
45,679
 7,851 7,279 - -
Other non-current assets
45,679
-
-
-
-
 - - - -
Total non-current assets
45,679
45,679
45,679
45,679
45,679
 93,753 33,092 116,350 121,368
Total assets
45,679
45,679
45,679
45,679
45,679
 $571,676 $386,419 $578,483 $513,306
3.4% 7.8% 9.0% 33.4% 23.1% 381.1%
Selected Year:
31-Mar
2020
Current Liabilities
Current Liabilities represent company's short-term dues to others. The most important part to watch for is short-term debt and accounts payables
15.7%
7.8% —

Accrued expenses and other current liabilities

3.4% —

Accrued research and development

2.6% —

Accounts payable

1.7% —

Current portion of notes payable and long-term royalty-based debt

0.2% —

Current portion of deferred revenue
Selected Year:
Accounts payable
$45,679
$45,679
$45,679
$45,679
$45,679
 $9,304 $13,215 $12,739 $13,455
Accrued employee compensation and benefits
$45,679
$45,679
$45,679
$45,679
$45,679
 11,526 - - -
Accrued research and development
-
-
$45,679
$45,679
$45,679
 44,973 19,831 19,249 17,230
Accrued expenses and other current liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
 3,552 22,310 49,773 39,920
Current portion of deferred revenue
$45,679
$45,679
$45,679
$45,679
$45,679
 11,169 1,847 1,623 1,188
Convertible preferred stock warrant liability
$45,679
-
-
-
-
 - - - -
Current portion of notes payable and long-term royalty-based debt
-
-
-
-
-
 - 11,802 19,034 8,706
Total current liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
 $80,524 $69,005 $102,418 $80,499
Selected Year:
31-Mar
2020
Non-Current Liabilities
The most critical items are revolving credit facility, term loans, and then notes - any forms of debt; in addition, pay attention to items like pension liabilites and leases- hidden debt
70.3%
33.4% —

Long term royalty-based debt non-current portion

23.1% —

Long-term debt

9.0% —

Notes payable

1.5% —

Leases

1.4% —

Other non-current liabilities

1.1% —

Long-term obligation to collaborator

0.8% —

Deferred revenue
Selected Year:
Deferred revenue
$45,679
$45,679
$45,679
$45,679
$45,679
 18,798 4,488 4,352 4,296
Long-term obligation to collaborator
-
-
-
$45,679
$45,679
 8,000 6,881 5,060 5,734
Notes payable
-
-
-
$45,679
$45,679
 50,565 48,298 43,100 46,269
Long-term debt
-
-
-
-
$45,679
 54,251 - 118,096 118,400
Long term royalty-based debt non-current portion
-
-
-
-
-
 - 155,256 162,897 171,237
Leases
-
-
-
-
-
 - - 8,850 7,786
Other non-current liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
 10,045 11,924 3,885 7,052
Total long-term liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
 $141,659 $226,847 $346,240 $360,774
Total Liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
 $222,183 $295,852 $448,658 $441,273
Selected Year:
31-Mar
2020
Equity
It's residue that is owned by shareholders after satisfying all of the liabilities with all of the assets; the larger the amount, the better the business is
14.0%
381.1% —

Additional paid-in capital

0.2% —

Accumulated other comprehensive income

0.0% —

Common stock
Selected Year:
Non-controlling interest
-
-
$45,679
$45,679
$45,679
 $2,627 $2,166 - -
Convertible preferred stock
$45,679
-
-
-
-
 - - - -
Preferred Stock
$45,679
$45,679
$45,679
$45,679
$45,679
 - - - -
Common stock
$45,679
$45,679
$45,679
$45,679
$45,679
 66 68 80 80
Accumulated deficit
$45,679
$45,679
$45,679
$45,679
$45,679
 (1,204,519) (1,525,704) (1,816,367) (1,885,138)
Additional paid-in capital
$45,679
$45,679
$45,679
$45,679
$45,679
 1,551,728 1,614,320 1,946,077 1,956,263
Accumulated other comprehensive income
$45,679
-
-
-
-
 - - 35 828
Accumulated other comprehensive (loss) income
-
$45,679
$45,679
-
-
 - (283) - -
Accumulated other comprehensive loss
-
-
-
$45,679
$45,679
 (409) - - -
Total Equity
$45,679
$45,679
$45,679
$45,679
$45,679
 $346,866 $88,401 $129,825 $72,033
Total Liabilities and Equity
$45,679
$45,679
$45,679
$45,679
$45,679
 $571,676 $386,419 $578,483 $513,306